QuidelOrtho Corp (NAS:QDEL)

$ 44.18 2.07 (4.92%) Market Cap: 2.96 Bil Enterprise Value: 5.49 Bil PE Ratio: 0 PB Ratio: 0.89 GF Score: 78/100

Q1 2024 QuidelOrtho Corp Earnings Call Transcript
7 days ago

$42.68 (-2.73%)

Earnings
QuidelOrtho Corp at Raymond James Institutional Investors Conference Transcript
Mar 05, 2024
Q4 2023 QuidelOrtho Corp Earnings Call Transcript
Feb 13, 2024

$66.77 (-3.98%)

Earnings
QuidelOrtho Corp at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
QuidelOrtho Corp at Evercore ISI HealthCONx Conference Transcript
Nov 30, 2023
Q3 2023 QuidelOrtho Corp Earnings Call Transcript
Nov 01, 2023

$60.5 (-0.95%)

Earnings
QuidelOrtho Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023
Q2 2023 QuidelOrtho Corp Earnings Call Transcript
Aug 08, 2023

$82.26 (-1.95%)

Earnings
QuidelOrtho Corp at William Blair Growth Stock Conference Transcript
Jun 06, 2023
Q1 2023 QuidelOrtho Corp Earnings Call Transcript
May 03, 2023

$93.23 (+1.95%)

Earnings
Quidelortho Corp at Raymond James Institutional Investors Conference Transcript
Mar 07, 2023
Q4 2022 Quidelortho Corp Earnings Call Transcript
Feb 15, 2023

$86.23 (+0.49%)

Earnings
Quidelortho Corp at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Quidelortho Corp 2022 Investor Day Transcript
Dec 13, 2022
Q3 2022 Quidelortho Corp Earnings Call Transcript
Nov 02, 2022

$88.73 (-3.05%)

Earnings
Quidelortho Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2022
Q2 2022 Quidelortho Corp Earnings Call Transcript
Aug 04, 2022

$97.17 (-4.34%)

Earnings

QuidelOrtho Corp at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 05:00PM GMT

Release Date Price: $71.88 (-2.54%)

Transcript

Casey Rene Woodring

JPMorgan Chase & Co, Research Division - Research Analyst

Great. Well, thank you, everybody, for coming today. Welcome to the JPM Healthcare Conference. My name is Casey Woodring. I'm from the Life Science Tools and Diagnostics team here at JPM.

Pleased to be joined today by QuidelOrtho. Here with me today, I have CEO, Doug Bryant. So I'll turn it over here to Doug in a minute for the presentation portion, and then we'll get to the Q&A session afterwards.

So with that, take it away, Doug.

Douglas C. Bryant

QuidelOrtho Corporation - President, CEO & Director

Thanks, Casey. Good morning, everybody. I'm pleased that we're going to be stuffed in this room. I'm pretty sure prevalence is going up for various respiratory things going around, including whatever I have -- so -- but I'm pleased to be here to talk about QuidelOrtho and talk about our progress.

With me here today are Joe Busky, our Chief Financial Officer; Juliet Cunningham, our Head of IR; and other -- and Rob Bujarski, our Chief Operating

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.